Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators
収録刊行物
-
- Anticancer Drugs
-
Anticancer Drugs 7 548-557, 1996